Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

687
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
687
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

720
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
720
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

83
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
83
Molecular Models02:00

Molecular Models

38.3K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
38.3K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

69
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
69

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

TURBO-RL: turbulence mitigation using reinforcement learning for severe optical aberrations.

Journal of the Optical Society of America. A, Optics, image science, and vision·2026
Same author

Alz-QNet: A quantum regression network for studying Alzheimer's gene interactions.

Computers in biology and medicine·2025
Same author

Modeling Brain Aging With Explainable Triamese ViT: Towards Deeper Insights Into Autism Disorder.

IEEE journal of biomedical and health informatics·2025
Same author

Improving Molecule Generation and Drug Discovery With a Knowledge-Enhanced Generative Model.

IEEE transactions on computational biology and bioinformatics·2024
Same author

Understanding the natural language of DNA using encoder-decoder foundation models with byte-level precision.

Bioinformatics advances·2024
Same author

Understanding the Natural Language of DNA using Encoder-Decoder Foundation Models with Byte-level Precision.

ArXiv·2024

相关实验视频

Updated: Jul 2, 2025

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

2.6K

通过知识增强型生成模型改进分子生成和药物发现.

Aditya Malusare1, Vaneet Aggarwal1

  • 1Edwardson School of Industrial Engineering and the Institute of Cancer Research, Purdue University.

ArXiv
|February 27, 2024
PubMed
概括
此摘要是机器生成的。

我们开发了KARL,一个知识增强的生成模型框架,将生物医学知识图与药物发现的生成模型集成在一起. 卡尔有效地产生有效和可合成的新型候选药物,优于现有方法.

更多相关视频

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
Modeling an Enzyme Active Site using Molecular Visualization Freeware
14:37

Modeling an Enzyme Active Site using Molecular Visualization Freeware

Published on: December 25, 2021

9.8K

相关实验视频

Last Updated: Jul 2, 2025

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

2.6K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
Modeling an Enzyme Active Site using Molecular Visualization Freeware
14:37

Modeling an Enzyme Active Site using Molecular Visualization Freeware

Published on: December 25, 2021

9.8K

科学领域:

  • 人工智能的人工智能
  • 化学信息学 化学信息学
  • 药物发现 药物发现 药物发现

背景情况:

  • 生成模型在分子生成方面取得了最先进的结果.
  • 在利用生物医学知识图表来增强生成药物发现模型方面存在差距.

研究的目的:

  • 弥合生成模型和生物医学知识图之间的差距.
  • 引入KARL,这是知识增强生成模型的新框架.

主要方法:

  • 开发了一个可扩展的方法来扩展知识图,同时保持语义完整性.
  • 集成知识图嵌入到基于扩散的生成模型中.
  • 使用上下文生物医学信息指导生成过程.

主要成果:

  • 卡尔成功地产生了具有特定特性的新药候选者.
  • 确保生成的分子的有效性和合成性.
  • 与最先进的模型相比,KARL在无条件和有针对性的生成任务上都表现出卓越的性能.

结论:

  • 卡尔代表了知识增强的产生性药物发现的重大进步.
  • 该框架有效地整合了生物医学知识,以改善候选药物的产生.
  • 这种方法有望加速新疗法的发现.